2019/03/01 | Press Release – ArchiMed launches takeover bid for Bomi Italia, international Medtech & Pharma services leader

The pan-European private equity healthcare specialist’s approximately €70 million bid has the support of Bomi Group’s founding family and other shareholders controlling some 70 percent of the quoted firm. March 1, 2019 – ArchiMed’s bid for Medtech and Pharma services provider Bomi Group is subject to a number of conditions, notably that 90 percent of all…

MORE

2018/06/09 | ArchiMed acquires majority stake in Soest Medical Group

Specialist healthcare investor ArchiMed has acquired a majority stake in Netherlands-based Soest Medical Group (SMG) which produces adhesives used during surgery. SMG has two brands: seller of reusable adhesives Eurotape and disposable adhesives provider Somed. Its revenues are growing at a rate of around 10 per cent annually, according to ArchiMed. With ArchiMed’s backing, SMG…

MORE

2018/06/08 | ArchiMed adds two as partners

France-based ArchiMed, a healthcare-focused private equity firm, have hired Benoît Adelus and André-Michel Ballester as partners. Adelus was the chairman and CEO of Sebia while Ballester is currently chairman of ArchiMed portfolio company Citieffe. PRESS RELEASE February 12, 2018 – Benoît Adelus and André-Michel Ballester are joining the senior management of European private equity healthcare…

MORE

2018/04/23 | Provepharm Life Solutions forms alliance with new strategic partners, ArchiMed and Téthys Invest

Marseille, April 23, 2018 – Provepharm Life Solutions announces today that ArchiMed and Téthys Invest have joined the company’s shareholder base as minority investors. Both are renowned investors with strong expertise in the healthcare sector. Beyond financial considerations, it was the specific support for the company’s long-term growth project and the entrepreneurial track record of its…

MORE